Molecular basis of Fanconi anemia

Haematologica

Volumn 83, Issue 6, 1998, Pages 533-542

  D'Apolito, Maria ^a   Zelante, Leopoldo ^a   Savoia, Anna ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

Complementation groups; FAA gene; FAC gene; Fanconi anemia; Mosaicism

Indexed keywords

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BONE MARROW DISEASE; FANCONI ANEMIA; GENE MUTATION; GENETIC COMPLEMENTATION; GENOME; HUMAN; MOLECULAR CLONING; MOSAICISM; PATHOGENESIS; PHENOTYPE;

CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; HUMANS; NUCLEAR PROTEINS; PROTEINS;

EID: 0031871477     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (115)

1. Fanconi G. Familiar constitutional panmyelocytopathy, Fanconi's anemia (FA). I. Clinical aspects. Semin Hematol 1967; 4:233-40.
2. Joenje H, Mathew C, Gluckman E. Fanconi anemia research: current status and prospects. Eur J Cancer 1995; 31A:268-72.
3. Rosendorff J, Berstein R, Macdougall L, Jenkins T. Fanconi anemia: another disease of unusually high prevalence in the Africans population of South Africa. Am J Med Genet 1987; 27:793-7.
4. Sansone R, Sansone G. The Italian contribution to the study of Fanconi's anemia. Pathologica 1990; 82:473-8.
5. Buchwald M, Joenje H, Auerbach AD. Fanconi anemia. In: Scriver C, Beaudet AL, Sly WS, Vallz D, eds. The Metabolic and Molecular Basis of Inherited Disease. 7th ed. New York: McGraw-Hill, 1997.
6. Alter BP, Young NS. The bone marrow failure syndromes. In: Nathan DG, Oski FA, eds. Hematology of Infancy and Childhood, I. 4th ed. Philadelphia: Saunders; 1993. p. 216-316.
7. Butturini A, Gale RP, Verlander PC, Adler-Brecher B, Gillio AP, Auerbach AD. Hematologic abnormalities in Fanconi anemia: an International Fanconi Anemia Registry study. Blood 1994; 84:1650-5.
8. Auerbach AD, Rogatko A, Schroeder-Kurth TM. International Fanconi anemia Registry: relation of clinical symptoms to diepoxybutane sensitivity. Blood 1989; 73:391-6.
9. Alter BP. Fanconi's anemia and its variability. Br J Haematol 1993; 85:9-14.
10. Giampietro PF, Adler-Brecher B, Verlander PC, Pavlakis SG, Davis JG, Auerbach AD. The need for more accurate and timely diagnosis in Fanconi anemia: a report from the International Fanconi Anemia Registry. Pediatrics 1993; 91:1116-20.
11. Addison M, Rice MS. The association of dyskeratosis congenita and Fanconi anemia. Med J Aust 1965; 1:797-9.
12. Nowell P, Bergman G, Besa E, Wilmoth D, Emanuel B. Progressive preleukemia with a chromosomally abnormal clone in a kindred with the Estren-Dameshek variant of Fanconi's anemia. Blood 1984; 64:1135-8.
13. Hedberg VA, Lipton JM. Thrombocytopenia with absent radii. A review of 100 cases. Am J Pediatr Hematol Oncol 1988; 10:51-64.
14. Farrell SA, Paes BA, Lewis ME. Fanconi anemia in a child previously diagnosed as Baller-Gerold syndrome. Am J Med Genet 1994; 50:98-9.
15. Rossbach Hc, Sutcliffe MJ, Haag MM, Grana NH, Rossi AR, Barbosa JL. Fanconi anemia in brothers initially diagnosed with VACTERL association with hydrocephalus, and subsequently with Baller-Gerold syndrome. Am J Med Genet 1996; 61:65-7.
16. Auerbach AD, Allen RG. Leukemia and preleukemia in Fanconi anemia patients. A review of the literature and report of the International Fanconi Anemia Registry. Cancer Genet Cytogen 1991; 5:1-12.
17. Swift M, Zimmerman D, McDonough ER. Squamous cell carcinomas in Fanconi's anemia. JAMA 1971; 216:325-6.
18. Somers GR, Tabrizi SN, Tiedemann K, Chow CW, Garland SM, Venter DJ. Squamous cell carcinoma of the tongue in a child with Fanconi anemia: a case report and review of the literature. Pediatr Pathol Lab Med 1995; 15:597-607.
19. Alter BP. Fanconi's anemia and malignancies. Am J Hematol 1996; 53:99-110.
20. Sasaky MS, Tonomura A. A high susceptibility of Fanconi's anemia to chromosome breakage by DNA cross-linking agents. Cancer Res 1973; 33:1829-36.
21. Sasaky MS. Is Fanconi's anaemia defective in a process essential to repair of DNA cross-link? Nature 1975; 257:501-3.
22. Wevrick R, Buchwald M. Mammalian DNA repair genes. Curr Opin Genet Dev 1993; 3:470-4.
23. Taylor AM, Byrd PJ, McConville CM, Thacker S. Genetic and cellular features of ataxia telangiectasia. Int J Radiat Biol 1994; 65:65-70.
24. German J. Bloom's syndrome. Dermatol Clin 1995; 13:7-18.
25. Friedberg E. Cockayne syndrome. A primary defect in DNA repair, transcription, both, or neither. Bioessays 1996; 18:731-8.
26. Ellis NA. DNA elicases in inherited human disorders. Curr Opin Genet Dev 1997; 7:354-63.
27. Copeland NE, Hanke CW, Michalak JA. The molecular basis of xeroderma pigmentosum. Dermatol Surg 1997; 23:447-55.
28. Auerbach AD, Wolman SR. Susceptibility of Fanconi's anemia fibroblasts to chromosome damage by carcinogens. Nature 1976; 261:494-6.
29. Isida R, Buchwald M. Susceptibility of Fanconi's anemia lymphoblasts to cross-linking and alkylating agents. Cancer Res 1982; 42:4000-6.
30. Berger R, Le Coniat M, Schaison G. Chromosome abnormalities in bone marrow of Fanconi anemia patients. Cancer Genet Cytogenet 1993; 65:47-50.
31. Alter BP, Scalise A, McCombs J, Najfeld V. Clonal chromosomal abnormalities in Fanconi's anaemia: what do they really mean? Br J Haematol 1993; 85: 627-30.
32. Fundia A, Gorla N, Larripa I. Spontaneous chromosome aberrations in Fanconi's anemia patients are located at fragile sites and acute myeloid leukemia breakpoints. Hereditas 1994; 120:47-50.
33. Joenje H, Arwert F, Eriksson AW, et al. Oxygen-dependence of chromosomal aberrations in Fanconi's anemia. Nature 1981; 290:142-3.
34. Schindler D, Hoehn H. Fanconi anemia mutation causes cellular susceptibility to ambient oxygen. Am J Hum Genet 1988; 43:429-35.
35. Joenje H, Gille JJP. Oxygen metabolism and chromosomal breakage in Fanconi anemia. In: Schroeder T, Auerbach AD, Obe G, eds. Fanconi anemia: clinical, cytogenetic and experimental aspects. Berlin: Springer-Verlag, 1989. p. 174-82.
36. Pagano G, Korkina LG, Degan P, et al. In vitro hypersensitivity to oxygen of Fanconi anemia (FA) cells is linked to ex vivo evidence for oxidative stress in FA homozygotes and heterozygotes. Blood 1997; 89:1111-2.
37. Kaiser TN, Lojewki A, Dougherty C, Juergens L, Sahar E, Latt SA. Flow cytometric characterization of the response of Fanconi's anemia cells to mitomycin C treatment. Cytometry 1982; 2:291-7.
38. Dutrillaux B, Aurias A, Dutrillaux AM, Buriot D, Prieur M. The cell cycle of lymphocytes in Fanconi anemia. Hum Genet 1982; 62:327-32.
39. Auerbach AD. Fanconi anemia diagnosis and the diepoxibutane (DEB) test. Exp Hematol 1993; 21:731-3.
40. Seyschab H, Friedl R, Sun Y, et al. Comparative evaluation of diepoxybutane sensitivity and cell cycle blockage in the diagnosis of Fanconi anemia. Blood 1995; 85:2233-7.
41. Guinan EC, Lopez KD, Huhn RD, Felser JM, Nathan DG. Evaluation of granulocyte-macrophage colony-stimulating factor for treatment of pancytopenia in children with Fanconi anemia. J Pediatr 1994; 124: 144-50.
42. Rackoff WR, Orazi A, Robinson CA, et al. Prolonged administration of granulocyte colony-stimulating factor (filgrastim) to with Fanconi anemia: a pilot study. Blood 1996; 88:1588-93.
43. Touraine RL, Bertrand Y, Foray P, Gilly J, Philippe N. Hepatic tumours during androgen therapy in Fanconi anaemia. Eur J Pediatr 1993; 152:691-3.
44. Gluckman E, Auerbach AD, Horowitz MM, et al. Bone marrow transplantation for Fanconi anemia. Blood 1995; 86:2856-62.
45. Duckworth-Rysiecki G, Cornish K, Clarke CA, Buchwald M. Identification of two complementation groups in Fanconi anemia. Somat Cell Mol Genet 1985; 11:35-41.
46. Strathdee CA, Duncan AMV, Buchwald M. Evidence for at least four Fanconi anemia genes including FACC on chromosome 9. Nature Genet 1992; 1:196-8:
47. Joenje H, Lo Ten Foe JR, Oostra AB, et al. Classification of Fanconi anemia patients by complementation analysis: evidence for a fifth genetic subtype. Blood 1995; 86:2156-60.
48. Joenje H, Oostra A, Wijker M, et al. Evidence for at least eight Fanconi anemia genes. Am J Hum Genet 1997; 61:940-4.
49. Buchwald M. Complementation groups: one or more per gene? Nature Genet 1995; 11:228-30.
50. Jakobs PM, Fiddler-Odell E, Reifsteck C, Olson S, Moses RE, Grompe M. Complementation group assignments in Fanconi anemia fibroblast cell lines from North America. Somat Cell Mol Genet 1997; 23:1-7.
51. Savoia A, Zatterale A, Del Principe D, Joenje H. Fanconi anaemia in Italy: high prevalence of complementation group A in two geographic clusters. Hum Genet 1996; 97:599-603.
52. Joenje H. European Fanconi Anaemia Research Group. Fanconi anaemia complementation groups in Germany and the Netherlands. Hum Genet 1996; 97:280-2.
53. Whitney M, Thayer M, Reifsteck C, et al. Microcell mediated chromosome transfer maps the Fanconi anemia group D gene to chromosome 3p. Nature Genet 1995; 11:341-3.
54. Strathedee CA., Gavish H, Shannon WR, Buchwald M. Cloning of cDNAs for Fanconi's anemia by functional complementation. Nature 1992; 356:763-7.
55. Gibson RA, Buchwald M, Roberts RG, Mathew CG. Characterization of the exon structure of the Fanconi anemia group C gene by vectorette PCR. Hum Mol Genet 1993; 2:35-8.
56. Hahn H, Wicking C, Zaphiropoulos PG, et al. Mutations of the human homolog of Drosophila patched in nevoid basal cell carcinoma syndrome. Cell 1996; 85: 841-51.
57. Wevrick C, Clarke CA, Buchwald M. Cloning and analysis of the murine Fanconi anemia group C cDNA. Hum Mol Genet 1993; 2:655-62.
58. Ching-Ying-Wong J, Alon N, Buchwald M. Cloning of the bovine and rat Fanconi anemia group C cDNA. Mamm Genome 1997; 8:522-5.
59. FAB Consortium. Positional cloning of the Fanconi anemia group A gene. Nature Genet 1996; 14:324-8.
60. Lo Ten Foe JR, Roimans AA, Bosnoyan-Collins L, et al. Expression of cloning of a cDNA for the major Fanconi anemia gene, FAA. Nature Genet 1996; 14:320-3.
61. Pronk JC, Gibson RA, Savoia A, et al. Localization of the Fanconi anemia complementation group A gene to chromosome 16q24.3. Nature Genet 1995; 11:338-40.
62. Savoia, Piemontese MR, Savino M, et al. Linkage analysis of Fanconi anemia in Italy and mapping of the complementation group A gene. Hum Genet 1997; 99:93-7.
63. Ianzano L, d'Apolito M, Centra M, et al. The genomic organization of the Fanconi anemia group A (FAA) gene. Genomics 1997; 41:309-14.
64. Murer-Orlando M, Llerena JC, Birjandi F, Gibson RA, Mathew CG. FACC gene mutations and early prenatal diagnosis of Fanconi's anaemia. Lancet 1993; 342: 686.
65. Gibson RA, Hajianpour A, Murer-Orlando M, Buchwald M, Mathew CG. A nonsense mutation and exon skipping in the Fanconi anaemia group C gene. Hum Mol Genet 1993; 2:797-9.
66. Whitney MA, Saito H, Jakobs PM, Gibson RA, Moses RE, Grompe M. A common mutation in the FACC gene causes Fanconi anaemia in Ashkenazi Jews. Nature Genet 1993; 4:202-5.
67. Verlander PC, Lin JD, Udono MU, et al. Mutation analysis of the Fanconi anemia gene FACC. Am J Hum Genet 1994; 54:595-601.
68. Lo Ten Foe JR, Rooimans MA, Joenje H, Arwert F. Novel frameshift mutation (1806insA) in exon 14 of the Fanconi anemia C gene, FAC. Hum Mutat 1996; 7: 264-5.
69. Lo Ten Foe JR, Barel MT, Thub P, Digweed M, Arwert F, Hoenje H. Sequence variations in the Fanconi anaemia gene, FAC: pathogenicity of 1860insA and R548X and recognition of D195V as a polymorphic variant. Hum Genet 1996; 98:522-3.
70. Gibson RA, Morgan NV, Goldstein LH, et al. Novel mutations and polymorphisms in the Fanconi anemia group C gene. Hum Mutat 1996; 8:140-8.
71. Lo Ten Foe JR, Kruyt FAE, Zweekhoest MBM, et al. Exon 6 skipping in the Fanconi Anemia C gene associated with a nonsense/missense mutation (775C→T) in exon 5. Hum Mutat 1997; 1:525-7.
72. Gavish H, dos Santos CC, Buchwald M. A Leu554-toPro substitution completely abolishes the functional complementing activity of the Fanconi anemia (FACC) protein. Hum Mol Genet 1993; 2:123-6.
73. Whitney MA, Jakobs P, Kaback M, Moses RE, Grompe M. The Ashkenazi Jewish Fanconi anemia mutation: incidence among patients and carrier frequency in the at-risk population. Hum Mutat 1994; 3:339-41.
74. Verlander PC, Kaporis A, Liu Q, Zhang Q, Seligsohn U, Auerbach AD. Carrier frequency of the IVS4+4A→T mutation of the Fanconi anemia gene FAC in the Ashkenazi Jewish population. Blood 1995; 86:4034-8.
75. Cox PM, Gibson RA, Morgan N, Brueton LA. VACTERL with hydrocephalus in twins due to Fanconi anemia (FA): mutations in the FAC gene. Am J Med Genet 1997; 68:86-90.
76. Yamashita T, Wu N, Kupfer G, et al. Clinical variability of Fanconi anemia (type C) results from expression of an amino terminal truncated Fanconi anemia complementation group C polypeptide with partial activity. Blood 1996; 87:4424-32.
77. Levran O, Erlich T, Magdalena N, et al. Sequence variation in the Fanconi anemia gene FAA. Proc Natl Acad USA 1997; 94:13051-6.
78. Savino M, Ianzano L, Strippoli P, et al. Mutations of the Fanconi anemia A gene (FAA) in Italian patients. Am J Hum Genet 1997; 61:1246-53.
79. Wijker M, Morgan NV, Herterich S, et al. Heterogeneous spectrum of mutations in the Fanconi anemia group A gene. Eur J Hum Genet 1998; in press.
80. Centra M, Memeo E, d'Apolito M, et al. Fine exon-intron structure of the Fanconi anemia group A (FAA) gen and characterization of two genomic deletions. Genomics 1998; in press.
81. Lo Ten Foe JR, Kwee ML, Rooimans MA, et al. Somatic mosaicism in Fanconi anemia: molecular basis and clinical significance. Eur J Hum Genet 1997; 5:137-48.
82. Klein CJ, Coovert DD, Bulman DE, et al. Somatic reversion/suppression in Duchenne muscular dystrophy (DMD): evidence supporting a frame-restoring mechanism in rare dystrophin-positive fibers. Am J Hum Genet 1992; 50:950-9.
83. Ellis NA, Lennon DJ, Proytcheva M, Alhadeff B, Henderson EE, German J. Somatic intragenic recombination within the mutated locus BLM can correct the high sister-chromatid exchange phenotype of Bloom syndrome cells. Am J Hum Genet 1995; 57:1019-27.
84. Hirschhorn R, Ruixi Yang D, PunkJM, Huie ML, Jiang CK, Kurlandsky LE. Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency. Nature Genet 1996; 6:290-5.
85. Krasnoshtein F, Buchwald M. Developmental expression of the Fac gene correlates with congenital defects in Fanconi anemia patients. Hum Mol Genet 1996; 5:85-93.
86. Savoia A, Centra M, Ianzano L, de Cillis GP, Zelante L, Buchwald M. Characterization of the 5′ region of the Fanconi anaemia group C (FACC) gene. Hum Mol Genet 1995; 8:1321-6.
87. Liebetrau W, Budde A, Savoia A, Grummt F, Hoehn H. p53 actives Fanconi anemia group C gene expression. Hum Mol Genet 1997; 2:277-83.
88. Yamashita T, Barber DL, Zhu Y, Wu N, D'Andrea AD. The Fanconi anemia polypeptide FACC is localized to the cytoplasm. Proc Natl Acad Sci USA 1994; 91:6712-6.
89. Youssoufian H. Localization of Fanconi anemia C protein to the cytoplasm of mammalian cells. Proc Natl Acad Sci 1994; 91:7975-9.
90. Youssoufian H, Auerbach AD, Verlander PC, Steimle V, Mach B. Identification of cytosolic proteins that bind to the Fanconi anemia complementation group C polypeptide in vitro. Evidence for a multimeric complex. J Biol Chem 1995; 270:9876-82.
91. Youssoufian H. Cytoplasmic localization of FAC is essential for the correction of a prerepair defect in Fanconi anemia group C cells. J Clin Invest 1996; 97:2003-10.
92. Hoshino T, Youssoufian H, Wang J, et al. The molecular chaperone GRP94 binds to a central domain within the group C Fanconi anemia protein [abstract]. Blood 1996; 88(Suppl 1):1734a.
93. Kupfer GM, Yamashita T, Naf D, Suliman A, Asano S, D'Andrea AD. The Fanconi anemia polypeptide, FAC, binds to the cyclin-dependent kinase, cdc2. Blood 1997; 90:1047-54.
94. Kruyt FAE, Waisfisz Q, Dijkmans LM, et al. Cytoplasmic localization of a functionally active Fanconi anemia group A-green fluorescent protein chimera in human 293 cells. Blood 1997; 90:3288-95.
95. Kupfer G, Naf D, Suliman A, Pulsipher M, D'Andrea AD. The Fanconi anemia proteins, FAA and FAC, interact to form a nuclear complex. Nature Genet 1997; 17:487-90.
96. Chen M, Tomkins DJ, Auerbach W, et al. Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anaemia. Nature Genet 1996; 12:448-51.
97. Whitney MA, Royle G, Low MJ, et al. Germ cell defects and hematopoietic hypersensitivity to gamma-interferon in mice with a targeted disruption of the Fanconi anemia C gene. Blood 1996; 88:49-58.
98. Hirana T, Koeffler HP. Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood 1995; 86:841-54.
99. Digweed M, Gunthert U, Schneider R, Seyschab H, Friedl R, Sperling K. Irreversible repression of DNA synthesis in Fanconi anemia cells is alleviated by the product of a novel cyclin-related gene. Mol Cell Biol 1995; 15:305-14.
100. Segal GM, Magenis RE, Brown M, et al. Repression of Fanconi anemia gene (FACC) expression inhibits growth of hematopoietic progenitor cells. J Clin Invest 1994; 94:846-52.
101. Diller L, Kassel J, Nelson CE, et al. p53 function as a cell cycle control in osteosarcoma. Mol Cell Biol 1990; 10:5772-81.
102. Kastan M, Zhan Q, El-Deiry, et al. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia telangiectasia. Cell 1992; 71:587-97.
103. Ridet A, Guillouf C, Duchaud E. Deregulated apoptosis is a hallmark of the Fanconi anemia syndrome. Cancer Res 1997; 57:1722-30.
104. Cumming RC, Liu JM, Youssoufian H, Buchwald M. Suppression of apoptosis in hematopoietic factor-dependent progenitor cell lines by expression of the FAC gene. Blood 1996; 88:4558-67.
105. Kruyt FA, Dijkmans LM, van den Berg TK, Joenje H. Fanconi Anemia genes act to suppress a cross-linker-inducible p53-independent apoptosis pathway in lymphoblastoid cell lines. Blood 1996; 87:938-48.
106. Kupfer GM, D'Andrea AD. The effect of the Fanconi anemia polypeptide, FAC, upon p53 induction and G2 checkpoint regulation. Blood 1996; 88:1019-25.
107. Rosselli F, Ridet A, Soussi T, Duchaud E, Alapetite C, Moustacchi E. p53-dependent pathway of radio-induced apoptosis is altered in Fanconi anemia. Oncogene 1995; 10:9-17.
108. Rathbun RK, Faulkner GR, Ostroski MH, et al. Inactivation of Fanconi anemia group C gene augments interferon-gamma-induced apoptotic responses in hematopoietic cells. Blood 1997; 90:974-85.
109. Papadopulo D, Guillouf C, Mohrenweiser H, Moustacchi E. Hypomutability in Fanconi anemia cells is associated with increased deletion frequency at the HPRT locus. Proc Natl Acad Sci USA 1990; 87:8383-7.
110. Laquerbe A, Moustacchi E, Fuscoe JC, Papadopoulo D. The molecular mechanism underlying formation of deletions in Fanconi anemia cells may involve a site specific recombination. Proc Natl Acad Sci USA 1995; 92:831-5.
111. Thyagarajan B, Campell C. Elevated homologous recombination activity in Fanconi anemia fribroblasts. J Biol Chem 1997; 272:23328-33.
112. D'Andrea A. Fanconi anemia forges a novel pathway. Nature Genet 1996; 14:240-2.
113. D'Andrea A, Grompe M. Molecular biology of Fanconi anemia: implication for diagnosis and therapy. Blood 1997; 90:1725-36.
114. Machl AW, Planitzer S, Kubbies M. A novel, membrane receptor-based retroviral vector for Fanconi anemia group C gene therapy. Gene Ther 1997; 4:339-45.
115. Fu K-L, Lo Ten Foe JR, Joenje H, Rao KW, Liu JM, Walsh CE. Functional correction of Fanconi group A hematopoietic cells by retroviral gene transfer. Blood 1997; 90:3296-303.